Gareth Wayne

Gareth Wayne is currently an Associate Director at GlaxoSmithKline, where they lead a team in the Emerging Specialties department focused on early drug discovery. Prior to this role, Gareth worked at Agrevo UK LTD as a Scientific Officer, conducting biochemical assays and mechanism of action studies. With extensive experience in assay development and compound profiling, they have contributed to various projects within GSK, including a PhD focused on disintegrin metallopeptidases.